Canada markets open in 29 minutes

Virax Biolabs Group Limited (VRAX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.6273+0.0073 (+1.18%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-03-31
2022-03-31
2021-03-31
Total Revenue
79.301
8.561
0
123.82
Cost of Revenue
70.266
9.926
0
133.254
Gross Profit
9.035
-1.365
0
-9.434
Operating Expenses
Research Development
709.782
397.109
433.743
120.221
Selling General and Administrative
6,298
5,334
1,300
514.883
Total Operating Expenses
7,007
5,731
1,734
635.104
Operating Income or Loss
-6,998
-5,733
-1,734
-644.538
Interest Expense
15.974
15.468
15.438
28.643
Total Other Income/Expenses Net
96.201
290.466
-0.753
0.266
Income Before Tax
-6,918
-5,458
-1,750
-672.915
Income Tax Expense
-
-
0
0
Income from Continuing Operations
-6,918
-5,458
-1,750
-672.915
Net Income
-6,924
-5,457
-1,709
-650.984
Net Income available to common shareholders
-6,924
-5,457
-1,709
-650.984
Basic EPS
-5.10
-5.10
-1.50
-0.57
Diluted EPS
-5.10
-5.10
-1.50
-0.57
Basic Average Shares
2,126
2,126
1,137
1,137
Diluted Average Shares
2,126
2,126
1,137
1,137